COVID-19
A recent patent application has revealed a novel combination therapy for treating COVID-19, utilizing a mix of natural supplements and medications. The therapy, designed by inventors Abdelhalim, Shaimaa Mahmoud Nashat Sayed and Gamaleldin, Mohamed Medhat Abdelwahab, aims to boost the immune system and reduce mortality rates among infected patients. The
COVID-19
Scientists at Hokkaido University have made significant advancements in developing an effective COVID-19 inactivated whole virus particle (WPV) vaccine. The research team, led by Toshiki Sekiya, was able to optimize the preparation method to preserve the structural integrity of the virus particle, which is crucial for inducing effective immunity against
COVID-19
Investigations into COVID-19 have revealed a new study on the identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches. Researchers from Istanbul University, in collaboration with other institutions, have made significant breakthroughs in the discovery of effective inhibitors for the treatment of COVID-19. The
COVID-19
Recent studies have highlighted the COVID-19 pandemic's impact on the environment, particularly the widespread use of chloroquine phosphate (CQP) in aquatic environments. According to a recent report, the use of CQP has led to its elevated levels in the aquatic environment, prompting concerns about its degradation and potential
COVID-19
Research from Tuskegee University emphasizes the pressing need for effective and affordable antiviral drugs to combat RNA viruses, which pose significant challenges due to their rapid mutation rates, high transmissibility, and ability to adapt to host immune responses and antiviral treatments. The World Health Organization has identified several diseases caused
COVID-19
New research has shed light on the effectiveness of COVID-19 vaccines in liver transplant recipients, highlighting the importance of continued vaccination efforts amidst waning adherence to booster doses. The study, conducted at the University of Milan, Italy, evaluated the anti-spike antibody responses in vaccinated liver transplant recipients after two initial
COVID-19
The World Health Organization's (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) has recommended the ongoing use of monovalent JN.1 and KP.2 vaccines against COVID-19. This decision is based on the analysis of evidence from various sources, including published and unpublished data, and considerations of
COVID-19
Diseases are a pervasive threat to the community, with a wide range of infectious agents and transmission methods. The recent resurgence of measles, a disease long thought eradicated, highlights the importance of understanding how diseases spread and how to protect against them. For healthcare professionals, including those completing online qualifications
COVID-19
Academic medical libraries in China played a vital role in providing health information services during the COVID-19 pandemic. However, they faced significant challenges in accessing and disseminating accurate health information to the public and healthcare professionals. These challenges were exacerbated by the limited integration of health information resources, inadequate customisation
COVID-19
Scientists have been studying mRNA since its discovery in 1961, but its potential in preventing infectious diseases and treating cancer and rare diseases has only recently gained attention. Robert F. Kennedy Jr.'s concerns about the safety of mRNA vaccines against COVID-19 have led to a surge in interest,
COVID-19
Researchers at Semmelweis University have conducted a study examining the potential risks associated with COVID-19 genetic vaccines. According to the study, which was published in the journal Pharmaceutics, these vaccines can induce a broad range of adverse events, including severe and chronic disabling symptoms. The researchers found that the incidence
COVID-19
Researchers from Anhui Medical University have made a groundbreaking discovery that could revolutionize the process of COVID-19 vaccine development. By using a humanized major histocompatibility complex transgenic mouse model, scientists have successfully demonstrated the potential of this tool in human leukocyte antigen-restricted T cell epitope screening. The study, published in
